Scientific and Regulatory Considerations for Efficacy Studies of Cytomegalovirus Vaccines

Abstract The considerable public health burden due to cytomegalovirus (CMV) supports current interest in vaccine development. Clinical studies intended to support regulatory action should be designed to demonstrate substantial evidence of effectiveness. However, design and conduct of clinical endpoi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Journal of infectious diseases 2020-03, Vol.221 (Supplement_1), p.S103-S108
Hauptverfasser:	Krause, Philip R, Roberts, Jeff
Format:	Artikel
Sprache:	eng
Schlagworte:	Congenital diseases Cytomegalovirus Cytomegalovirus - immunology Cytomegalovirus Infections - etiology Cytomegalovirus Infections - prevention & control Cytomegalovirus Infections - transmission Cytomegalovirus Vaccines - immunology Hematopoietic Stem Cell Transplantation - adverse effects Humans Infectious Disease Transmission, Vertical - prevention & control Organ Transplantation - adverse effects Public health Rubella Transplantation Vaccine development Vaccines
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!